10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 314 filers reported holding 10X GENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,810,819 | -29.3% | 43,876 | -4.3% | 0.00% | -25.0% |
| Q2 2023 | $2,560,200 | +16.8% | 45,849 | +16.7% | 0.00% | 0.0% |
| Q1 2023 | $2,191,052 | +163.6% | 39,280 | +72.3% | 0.00% | +100.0% |
| Q4 2022 | $831,318 | +78.8% | 22,802 | +39.8% | 0.00% | +100.0% |
| Q3 2022 | $465,000 | -64.8% | 16,308 | -46.6% | 0.00% | -66.7% |
| Q2 2022 | $1,321,000 | -40.0% | 30,529 | +5.5% | 0.00% | -25.0% |
| Q1 2022 | $2,202,000 | -29.0% | 28,948 | +39.1% | 0.00% | -33.3% |
| Q4 2021 | $3,100,000 | -9.9% | 20,812 | -11.9% | 0.01% | -14.3% |
| Q3 2021 | $3,439,000 | -25.8% | 23,626 | -0.1% | 0.01% | -30.0% |
| Q2 2021 | $4,633,000 | +16.5% | 23,659 | +7.7% | 0.01% | 0.0% |
| Q1 2021 | $3,976,000 | +865.0% | 21,967 | +654.4% | 0.01% | +900.0% |
| Q4 2020 | $412,000 | – | 2,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |